These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

633 related articles for article (PubMed ID: 27365313)

  • 1. Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease.
    Ellebrecht CT; Bhoj VG; Nace A; Choi EJ; Mao X; Cho MJ; Di Zenzo G; Lanzavecchia A; Seykora JT; Cotsarelis G; Milone MC; Payne AS
    Science; 2016 Jul; 353(6295):179-84. PubMed ID: 27365313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigen-specific B cell depletion for precision therapy of mucosal pemphigus vulgaris.
    Lee J; Lundgren DK; Mao X; Manfredo-Vieira S; Nunez-Cruz S; Williams EF; Assenmacher CA; Radaelli E; Oh S; Wang B; Ellebrecht CT; Fraietta JA; Milone MC; Payne AS
    J Clin Invest; 2020 Dec; 130(12):6317-6324. PubMed ID: 32817591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenic IgG antibodies against desmoglein 3 in pemphigus vulgaris are regulated by HLA-DRB1*04:02-restricted T cells.
    Eming R; Hennerici T; Bäcklund J; Feliciani C; Visconti KC; Willenborg S; Wohde J; Holmdahl R; Sønderstrup G; Hertl M
    J Immunol; 2014 Nov; 193(9):4391-9. PubMed ID: 25252957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Autoreactive B Cell Subpopulations in Peripheral Blood of Autoimmune Patients With Pemphigus Vulgaris.
    Pollmann R; Walter E; Schmidt T; Waschke J; Hertl M; Möbs C; Eming R
    Front Immunol; 2019; 10():1375. PubMed ID: 31258541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desmoglein 3-specific CD4+ T cells induce pemphigus vulgaris and interface dermatitis in mice.
    Takahashi H; Kouno M; Nagao K; Wada N; Hata T; Nishimoto S; Iwakura Y; Yoshimura A; Yamada T; Kuwana M; Fujii H; Koyasu S; Amagai M
    J Clin Invest; 2011 Sep; 121(9):3677-88. PubMed ID: 21821914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel system evaluating in vivo pathogenicity of desmoglein 3-reactive T cell clones using murine pemphigus vulgaris.
    Takahashi H; Amagai M; Nishikawa T; Fujii Y; Kawakami Y; Kuwana M
    J Immunol; 2008 Jul; 181(2):1526-35. PubMed ID: 18606708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting inducible costimulator expressed on CXCR5
    Kim AR; Han D; Choi JY; Seok J; Kim SE; Seo SH; Takahashi H; Amagai M; Park SH; Kim SC; Shin EC; Kim JH
    J Allergy Clin Immunol; 2020 Nov; 146(5):1070-1079.e8. PubMed ID: 32311391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pemphigus: Current and Future Therapeutic Strategies.
    Didona D; Maglie R; Eming R; Hertl M
    Front Immunol; 2019; 10():1418. PubMed ID: 31293582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pemphigus vulgaris and its active disease mouse model.
    Amagai M
    Curr Dir Autoimmun; 2008; 10():167-81. PubMed ID: 18460885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoreactive T cells in the immune pathogenesis of pemphigus vulgaris.
    Amber KT; Staropoli P; Shiman MI; Elgart GW; Hertl M
    Exp Dermatol; 2013 Nov; 22(11):699-704. PubMed ID: 24433179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the T cells that are potentially involved in autoantibody production in pemphigus vulgaris.
    Hertl M; Riechers R
    J Dermatol; 1999 Nov; 26(11):748-52. PubMed ID: 10635617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoadsorption of Desmoglein-3-Specific IgG Abolishes the Blister-Inducing Capacity of Pemphigus Vulgaris IgG in Neonatal Mice.
    Hofrichter M; Dworschak J; Emtenani S; Langenhan J; Weiß F; Komorowski L; Zillikens D; Stöcker W; Probst C; Schmidt E; Goletz S
    Front Immunol; 2018; 9():1935. PubMed ID: 30233569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulating Immunity to Treat Autoimmune Disease.
    Amagai M
    N Engl J Med; 2016 Oct; 375(15):1487-1489. PubMed ID: 27732810
    [No Abstract]   [Full Text] [Related]  

  • 14. Development of chimeric molecules for recognition and targeting of antigen-specific B cells in pemphigus vulgaris.
    Proby CM; Ota T; Suzuki H; Koyasu S; Gamou S; Shimizu N; Wahl JK; Wheelock MJ; Nishikawa T; Amagai M
    Br J Dermatol; 2000 Feb; 142(2):321-30. PubMed ID: 10730768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunophenotyping in pemphigus reveals a T
    Holstein J; Solimani F; Baum C; Meier K; Pollmann R; Didona D; Tekath T; Dugas M; Casadei N; Hudemann C; Polakova A; Matthes J; Schäfer I; Yazdi AS; Eming R; Hertl M; Pfützner W; Ghoreschi K; Möbs C
    J Allergy Clin Immunol; 2021 Jun; 147(6):2358-2369. PubMed ID: 33221382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenic autoantibody production requires loss of tolerance against desmoglein 3 in both T and B cells in experimental pemphigus vulgaris.
    Tsunoda K; Ota T; Suzuki H; Ohyama M; Nagai T; Nishikawa T; Amagai M; Koyasu S
    Eur J Immunol; 2002 Mar; 32(3):627-33. PubMed ID: 11857336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies against keratinocyte antigens other than desmogleins 1 and 3 can induce pemphigus vulgaris-like lesions.
    Nguyen VT; Ndoye A; Shultz LD; Pittelkow MR; Grando SA
    J Clin Invest; 2000 Dec; 106(12):1467-79. PubMed ID: 11120754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoreactive B-cell elimination by pathogenic IgG specific for the same antigen: implications for peripheral tolerance.
    Ota T; Aoki-Ota M; Tsunoda K; Nishikawa T; Koyasu S; Amagai M
    Int Immunol; 2008 Oct; 20(10):1351-60. PubMed ID: 18765425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell receptor gene usage in desmoglein-3-specific T lymphocytes from patients with pemphigus vulgaris.
    Hacker-Foegen MK; Fairley JA; Lin MS
    J Invest Dermatol; 2003 Dec; 121(6):1365-72. PubMed ID: 14675184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen-independent development of Foxp3+ regulatory T cells suppressing autoantibody production in experimental pemphigus vulgaris.
    Yokoyama T; Matsuda S; Takae Y; Wada N; Nishikawa T; Amagai M; Koyasu S
    Int Immunol; 2011 Jun; 23(6):365-73. PubMed ID: 21525154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.